Literature DB >> 24297510

Distinct roles of Akt1 in regulating proliferation, migration and invasion in HepG2 and HCT 116 cells.

Liang Chen1, Qiao-Hui Kang1, Ying Chen1, Ya-Hong Zhang2, Qian Li2, Song-Qiang Xie1, Chao-Jie Wang2.   

Abstract

Elucidating the effects of genes involved in tumors may improve therapeutic strategies for human cancer. Recently, several studies discovered that Akt1 plays a dual role in mediating cell proliferation, migration and invasion, depending on the cell type. However, the pathophysiological role of Akt1 in hepatocellular carcinoma (HCC) and colorectal carcinoma cells remains poorly understood. In the present study, we transfected the Akt1-expressing plasmids into the tumor cells that expressed only low levels of Akt1. The migration and invasion abilities were analyzed in 24-well Boyden chambers. The expression of proteins was detected using western blot analysis. Our results demonstrated that overexpression of Akt1 significantly enhanced the proliferation rates and promoted the colony formation in both HepG2 and HCT 116 cells. When treated with wortmannin, the ability to form colonies was significantly attenuated in both cell lines. Of note, enforced expression of Akt1 induced HepG2 cell migration and invasion; by contrast, upregulation of Akt1 expression suppressed the migration and invasion of HCT 116 cells. Subsequent mechanistic investigations revealed that upregulation of Akt1 markedly induced the expression of Bcl-2 and NF-κB in both types of tumor cells. Notably, we observed a similar increase of MMP2, MMP9, HIF1α and VEGF in HCC cells, whereas Akt1 significantly suppressed the expression of these molecules in colorectal carcinoma cells. These data suggest a dual role for Akt1 in tumor cell migration and invasion and highlight the cell type-specific actions of Akt1 kinases in the regulation of cell motility.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24297510     DOI: 10.3892/or.2013.2879

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  8 in total

1.  Nodal pathway activation due to Akt1 suppression is a molecular switch for prostate cancer cell epithelial-to-mesenchymal transition and metastasis.

Authors:  Abdulrahman Alwhaibi; Arti Verma; Sandeep Artham; Mir S Adil; Payaningal R Somanath
Journal:  Biochem Pharmacol       Date:  2019-06-14       Impact factor: 5.858

Review 2.  The unconventional role of Akt1 in the advanced cancers and in diabetes-promoted carcinogenesis.

Authors:  Abdulrahman Alwhaibi; Arti Verma; Mir S Adil; Payaningal R Somanath
Journal:  Pharmacol Res       Date:  2019-05-09       Impact factor: 7.658

3.  Akt1 inhibition promotes breast cancer metastasis through EGFR-mediated β-catenin nuclear accumulation.

Authors:  Wei Li; Jiu-Zhou Hou; Jie Niu; Zhuo-Qing Xi; Chang Ma; Hua Sun; Chao-Jie Wang; Dong Fang; Qin Li; Song-Qiang Xie
Journal:  Cell Commun Signal       Date:  2018-11-16       Impact factor: 5.712

4.  Systematic Elucidation of the Potential Mechanisms of Core Chinese Materia Medicas in Treating Liver Cancer Based on Network Pharmacology.

Authors:  Zhulin Wu; Lina Yang; Li He; Lianan Wang; Lisheng Peng
Journal:  Evid Based Complement Alternat Med       Date:  2020-04-24       Impact factor: 2.629

Review 5.  Distinct functions of AKT isoforms in breast cancer: a comprehensive review.

Authors:  Nico Hinz; Manfred Jücker
Journal:  Cell Commun Signal       Date:  2019-11-21       Impact factor: 5.712

6.  Data Mining, Network Pharmacology, and Molecular Docking Explore the Effects of Core Traditional Chinese Medicine Prescriptions in Patients with Rectal Cancer and Qi and Blood Deficiency Syndrome.

Authors:  Shiyu Ma; Lin Zheng; Lan Zheng; Xiaolan Bian
Journal:  Evid Based Complement Alternat Med       Date:  2021-08-02       Impact factor: 2.629

7.  Using machine learning algorithms to identify genes essential for cell survival.

Authors:  Santosh Philips; Heng-Yi Wu; Lang Li
Journal:  BMC Bioinformatics       Date:  2017-10-03       Impact factor: 3.169

8.  Inhibition of AKT1 signaling promotes invasion and metastasis of non-small cell lung cancer cells with K-RAS or EGFR mutations.

Authors:  Guanhua Rao; Mariaelena Pierobon; In-Kyu Kim; Wei-Hsun Hsu; Jianghong Deng; Yong-Wha Moon; Emanuel F Petricoin; Yu-Wen Zhang; Yisong Wang; Giuseppe Giaccone
Journal:  Sci Rep       Date:  2017-08-01       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.